Angela A. Armstrong

Array ( [id] => 6568565 [patent_doc_number] => 20100273190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'PKHDL1, A HOMOLOG OF THE AUTOSOMAL RECESSIVE KIDNEY DISEASE GENE' [patent_app_type] => utility [patent_app_number] => 12/613753 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22330 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273190.pdf [firstpage_image] =>[orig_patent_app_number] => 12613753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561734 [patent_doc_number] => 20110275567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'AQUEOUS COMPOSITION CONTAINING FOLLICLE-STIMULATING HORMONE' [patent_app_type] => utility [patent_app_number] => 13/127108 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5342 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275567.pdf [firstpage_image] =>[orig_patent_app_number] => 13127108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6313941 [patent_doc_number] => 20100111902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/609998 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13609 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111902.pdf [firstpage_image] =>[orig_patent_app_number] => 12609998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431262 [patent_doc_number] => 20100143383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'OXGR1 AGONISTS FOR USE IN THERAPIES FOR METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/608069 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14141 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143383.pdf [firstpage_image] =>[orig_patent_app_number] => 12608069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502210 [patent_doc_number] => 20110263821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'PROGNOSIS AND RISK ASSESSMENT IN STROKE PATIENTS BY DETERMINING THE LEVEL OF MARKER PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/125911 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 79 [patent_no_of_words] => 19658 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263821.pdf [firstpage_image] =>[orig_patent_app_number] => 13125911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090373 [patent_doc_number] => 20110218149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF KIDNEY DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/124139 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4495 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218149.pdf [firstpage_image] =>[orig_patent_app_number] => 13124139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014665 [patent_doc_number] => 20110223106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'GRANIN PROTEINS AS MARKERS OF HEART DISEASE' [patent_app_type] => utility [patent_app_number] => 13/122131 [patent_app_country] => US [patent_app_date] => 2009-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 25418 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223106.pdf [firstpage_image] =>[orig_patent_app_number] => 13122131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6256486 [patent_doc_number] => 20100029489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'SUCROSE TRANSPORT PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/568846 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11191 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029489.pdf [firstpage_image] =>[orig_patent_app_number] => 12568846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561730 [patent_doc_number] => 20110275563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Use of CTGF as a Cardioprotectant' [patent_app_type] => utility [patent_app_number] => 13/063860 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 30999 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275563.pdf [firstpage_image] =>[orig_patent_app_number] => 13063860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6526721 [patent_doc_number] => 20100015047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Lung-Expressed Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/551449 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 36051 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015047.pdf [firstpage_image] =>[orig_patent_app_number] => 12551449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239813 [patent_doc_number] => 20120148552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'METHOD AND COMPOSITIONS FOR ENHANCED ANTI-TUMOR EFFECTOR FUNCTIONING OF T CELLS' [patent_app_type] => utility [patent_app_number] => 13/060908 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 13523 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374507 [patent_doc_number] => 20100081142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'BIOMARKERS FOR KIDNEY DISEASES AND METHOD FOR USING SAME' [patent_app_type] => utility [patent_app_number] => 12/540146 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5548 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081142.pdf [firstpage_image] =>[orig_patent_app_number] => 12540146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212365 [patent_doc_number] => 20110135665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'METHODS FOR TREATING REPERFUSION INJURIES' [patent_app_type] => utility [patent_app_number] => 13/056973 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 10700 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135665.pdf [firstpage_image] =>[orig_patent_app_number] => 13056973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555171 [patent_doc_number] => 08329643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'PIMAP39 modulates LPS-induced inflammatory response' [patent_app_type] => utility [patent_app_number] => 13/000545 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 10090 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13000545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8749551 [patent_doc_number] => 08415384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade' [patent_app_type] => utility [patent_app_number] => 12/997485 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9922932 [patent_doc_number] => 08980894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure' [patent_app_type] => utility [patent_app_number] => 12/482481 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 6280 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12482481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296728 [patent_doc_number] => 20100160607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'p16 MEDIATED REGULATION OF NMDA RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/481412 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15946 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160607.pdf [firstpage_image] =>[orig_patent_app_number] => 12481412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254668 [patent_doc_number] => 08618084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Aldosterone induced vascular elastin production' [patent_app_type] => utility [patent_app_number] => 12/937534 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 44 [patent_no_of_words] => 17934 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083617 [patent_doc_number] => 20110144019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'METHOD OF TREATING CHRONIC HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 12/992667 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19428 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144019.pdf [firstpage_image] =>[orig_patent_app_number] => 12992667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315897 [patent_doc_number] => 20090280495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'ACTIVATING MUTATIONS OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA (PDGFRA) AS DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS' [patent_app_type] => utility [patent_app_number] => 12/466218 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28319 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280495.pdf [firstpage_image] =>[orig_patent_app_number] => 12466218 [rel_patent_id] =>[rel_patent_doc_number] =>)